Please enable JavaScript to continue using this application.

Compare $MRVI vs $PSNL | Chartloom

Compare

$MRVI vs $PSNL

Maravai LifeSciences Holdings Inc · Personalis Inc

MRVI

Maravai LifeSciences Holdings Inc

PSNL

Personalis Inc

Compare $MRVI vs $PSNL

Comparing Maravai LifeSciences Holdings Inc and Personalis Inc

MRVIMaravai LifeSciences Holdings Inc

PSNLPersonalis Inc

MRVIMaravai LifeSciences Holdings Inc

Market cap

$1.92B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

8.68x

Rev growth (TTM)

-3.3%

YTD performance

118.8%

52W performance

123.4%

FCF yield

-1.8%

PSNLPersonalis Inc

Market cap

$1.71B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

17.58x

Rev growth (TTM)

-13.3%

YTD performance

103.8%

52W performance

84.3%

FCF yield

-5.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

MRVI

PSNL

Detailed metrics comparison

MRVI

Maravai LifeSciences Holdings Inc

PSNL

Personalis Inc

Market Cap

MRVI$1.92B

PSNL$1.71B

Enterprise Value

MRVI$2.03B

PSNL$1.61B

Price

MRVI$7.44

PSNL$16.00

P/E Ratio

MRVIN/A

PSNLN/A

P/S Ratio

MRVI9.20x

PSNL24.52x

EV/Sales

MRVI9.71x

PSNL23.18x

EV/EBITDA

MRVI24.69x

PSNL0.00x

P/B Ratio

MRVI10.03x

PSNL7.39x

P/FCF Ratio

MRVIN/A

PSNLN/A

EV/FCF

MRVI-57.75x

PSNL-15.99x

PEG Ratio

MRVIN/A

PSNLN/A

Forward P/E (NTM)

MRVIN/A

PSNLN/A

Forward P/S (NTM)

MRVI8.68x

PSNL17.58x

Revenue (TTM)

MRVI$209M

PSNL$70M

Revenue Growth (YoY)

MRVI-3.3%

PSNL-13.3%

Forward Rev Growth

MRVI6.5%

PSNL37.3%

Gross Margin (TTM)

MRVI34.9%

PSNL12.7%

Operating Margin (TTM)

MRVI0.0%

PSNL0.0%

EBITDA Margin (TTM)

MRVI-10.4%

PSNL-150.1%

Net Margin (TTM)

MRVI-37.1%

PSNL-153.8%

FCF Margin (TTM)

MRVI-16.8%

PSNL-144.9%

Net Income (TTM)

MRVI$-77M

PSNL$-107M

FCF (TTM)

MRVI$-35M

PSNL$-101M

EPS (TTM)

MRVI-$0.52

PSNL-$1.02

ROE (TTM)

MRVI-3542.0%

PSNL-4647.0%

ROA (TTM)

MRVI-1054.0%

PSNL-3530.0%

ROIC (TTM)

MRVI-1572.0%

PSNL-4601.0%

Cash

MRVI$70M

PSNL$94M

Debt

MRVI$177M

PSNL$898K

Net Cash/Debt

MRVI$-107M

PSNL$93M

Current Ratio (TTM)

MRVI4.05x

PSNL5.28x

Quick Ratio (TTM)

MRVI2.63x

PSNL4.91x

Debt/Equity (TTM)

MRVI0.86x

PSNL0.00x

Debt/Assets (TTM)

MRVI0.0%

PSNL0.0%

Interest Coverage (TTM)

MRVIN/A

PSNLN/A

Net Debt/EBITDA (TTM)

MRVI0.00x

PSNL0.00x

Beta

MRVI0.63

PSNL2.37

52W Performance

MRVI123.4%

PSNL84.3%

YTD Performance

MRVI118.8%

PSNL103.8%

% from 52W High

MRVI-21.0%

PSNL-15.3%

% from 52W Low

MRVI192.3%

PSNL222.9%

Asset Turnover (TTM)

MRVI0.28x

PSNL0.23x

FCF Yield (TTM)

MRVI-1.8%

PSNL-5.9%

Earnings Yield (TTM)

MRVI-4.0%

PSNL-6.3%

Dividend Yield (TTM)

MRVIN/A

PSNLN/A

Rule of 40

MRVI-20.1

PSNL-158.2

EV/GP/RG

MRVI4.63

PSNL4.29

Ticker research

View MRVI research View PSNL research

Metric	MRVI Maravai LifeSciences Holdings Inc	PSNL Personalis Inc
Market & Valuation
Market Cap	$1.92B	$1.71B
Enterprise Value	$2.03B	$1.61B
Price	$7.44	$16.00
P/E Ratio	N/A	N/A
P/S Ratio	9.20x	24.52x
EV/Sales	9.71x	23.18x
EV/EBITDA	24.69x	0.00x
P/B Ratio	10.03x	7.39x
P/FCF Ratio	N/A	N/A
EV/FCF	-57.75x	-15.99x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	8.68x	17.58x
Revenue & Growth
Revenue (TTM)	$209M	$70M
Revenue Growth (YoY)	-3.3%	-13.3%
Forward Rev Growth	6.5%	37.3%
Profitability
Gross Margin (TTM)	34.9%	12.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-10.4%	-150.1%
Net Margin (TTM)	-37.1%	-153.8%
FCF Margin (TTM)	-16.8%	-144.9%
Net Income (TTM)	$-77M	$-107M
FCF (TTM)	$-35M	$-101M
EPS (TTM)	-$0.52	-$1.02
ROE (TTM)	-3542.0%	-4647.0%
ROA (TTM)	-1054.0%	-3530.0%
ROIC (TTM)	-1572.0%	-4601.0%
Financial Health
Cash	$70M	$94M
Debt	$177M	$898K
Net Cash/Debt	$-107M	$93M
Current Ratio (TTM)	4.05x	5.28x
Quick Ratio (TTM)	2.63x	4.91x
Debt/Equity (TTM)	0.86x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.63	2.37
52W Performance	123.4%	84.3%
YTD Performance	118.8%	103.8%
% from 52W High	-21.0%	-15.3%
% from 52W Low	192.3%	222.9%
Efficiency & Yields
Asset Turnover (TTM)	0.28x	0.23x
FCF Yield (TTM)	-1.8%	-5.9%
Earnings Yield (TTM)	-4.0%	-6.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-20.1	-158.2
EV/GP/RG	4.63	4.29
Ticker research	View MRVI research	View PSNL research

Valuation

P/S Ratio

MRVI

9.20x

PSNL

24.52x

EV/FCF

MRVI

-57.75x

PSNL

-15.99x

Growth & revenue

Revenue Growth TTM

MRVI

-3.3%

PSNL

-13.3%

Forward Revenue Growth

PSNL

37.3%

MRVI

6.5%

Profitability & performance

Gross Margin

MRVI

34.9%

PSNL

12.7%

ROE

MRVI

-3542.0%

PSNL

-4647.0%

FCF Yield %

MRVI

-1.8%

PSNL

-5.9%

52-Week Performance

MRVI

123.4%

PSNL

84.3%

Detailed metrics comparison

MRVI

Maravai LifeSciences Holdings Inc

PSNL

Personalis Inc

Market Cap

MRVI$1.92B

PSNL$1.71B

Enterprise Value

MRVI$2.03B

PSNL$1.61B

Price

MRVI$7.44

PSNL$16.00

P/E Ratio

MRVIN/A

PSNLN/A

P/S Ratio

MRVI9.20x

PSNL24.52x

EV/Sales

MRVI9.71x

PSNL23.18x

EV/EBITDA

MRVI24.69x

PSNL0.00x

P/B Ratio

MRVI10.03x

PSNL7.39x

P/FCF Ratio

MRVIN/A

PSNLN/A

EV/FCF

MRVI-57.75x

PSNL-15.99x

PEG Ratio

MRVIN/A

PSNLN/A

Forward P/E (NTM)

MRVIN/A

PSNLN/A

Forward P/S (NTM)

MRVI8.68x

PSNL17.58x

Revenue (TTM)

MRVI$209M

PSNL$70M

Revenue Growth (YoY)

MRVI-3.3%

PSNL-13.3%

Forward Rev Growth

MRVI6.5%

PSNL37.3%

Gross Margin (TTM)

MRVI34.9%

PSNL12.7%

Operating Margin (TTM)

MRVI0.0%

PSNL0.0%

EBITDA Margin (TTM)

MRVI-10.4%

PSNL-150.1%

Net Margin (TTM)

MRVI-37.1%

PSNL-153.8%

FCF Margin (TTM)

MRVI-16.8%

PSNL-144.9%

Net Income (TTM)

MRVI$-77M

PSNL$-107M

FCF (TTM)

MRVI$-35M

PSNL$-101M

EPS (TTM)

MRVI-$0.52

PSNL-$1.02

ROE (TTM)

MRVI-3542.0%

PSNL-4647.0%

ROA (TTM)

MRVI-1054.0%

PSNL-3530.0%

ROIC (TTM)

MRVI-1572.0%

PSNL-4601.0%

Cash

MRVI$70M

PSNL$94M

Debt

MRVI$177M

PSNL$898K

Net Cash/Debt

MRVI$-107M

PSNL$93M

Current Ratio (TTM)

MRVI4.05x

PSNL5.28x

Quick Ratio (TTM)

MRVI2.63x

PSNL4.91x

Debt/Equity (TTM)

MRVI0.86x

PSNL0.00x

Debt/Assets (TTM)

MRVI0.0%

PSNL0.0%

Interest Coverage (TTM)

MRVIN/A

PSNLN/A

Net Debt/EBITDA (TTM)

MRVI0.00x

PSNL0.00x

Beta

MRVI0.63

PSNL2.37

52W Performance

MRVI123.4%

PSNL84.3%

YTD Performance

MRVI118.8%

PSNL103.8%

% from 52W High

MRVI-21.0%

PSNL-15.3%

% from 52W Low

MRVI192.3%

PSNL222.9%

Asset Turnover (TTM)

MRVI0.28x

PSNL0.23x

FCF Yield (TTM)

MRVI-1.8%

PSNL-5.9%

Earnings Yield (TTM)

MRVI-4.0%

PSNL-6.3%

Dividend Yield (TTM)

MRVIN/A

PSNLN/A

Rule of 40

MRVI-20.1

PSNL-158.2

EV/GP/RG

MRVI4.63

PSNL4.29

Ticker research

View MRVI research View PSNL research

Metric	MRVI Maravai LifeSciences Holdings Inc	PSNL Personalis Inc
Market & Valuation
Market Cap	$1.92B	$1.71B
Enterprise Value	$2.03B	$1.61B
Price	$7.44	$16.00
P/E Ratio	N/A	N/A
P/S Ratio	9.20x	24.52x
EV/Sales	9.71x	23.18x
EV/EBITDA	24.69x	0.00x
P/B Ratio	10.03x	7.39x
P/FCF Ratio	N/A	N/A
EV/FCF	-57.75x	-15.99x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	8.68x	17.58x
Revenue & Growth
Revenue (TTM)	$209M	$70M
Revenue Growth (YoY)	-3.3%	-13.3%
Forward Rev Growth	6.5%	37.3%
Profitability
Gross Margin (TTM)	34.9%	12.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-10.4%	-150.1%
Net Margin (TTM)	-37.1%	-153.8%
FCF Margin (TTM)	-16.8%	-144.9%
Net Income (TTM)	$-77M	$-107M
FCF (TTM)	$-35M	$-101M
EPS (TTM)	-$0.52	-$1.02
ROE (TTM)	-3542.0%	-4647.0%
ROA (TTM)	-1054.0%	-3530.0%
ROIC (TTM)	-1572.0%	-4601.0%
Financial Health
Cash	$70M	$94M
Debt	$177M	$898K
Net Cash/Debt	$-107M	$93M
Current Ratio (TTM)	4.05x	5.28x
Quick Ratio (TTM)	2.63x	4.91x
Debt/Equity (TTM)	0.86x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.63	2.37
52W Performance	123.4%	84.3%
YTD Performance	118.8%	103.8%
% from 52W High	-21.0%	-15.3%
% from 52W Low	192.3%	222.9%
Efficiency & Yields
Asset Turnover (TTM)	0.28x	0.23x
FCF Yield (TTM)	-1.8%	-5.9%
Earnings Yield (TTM)	-4.0%	-6.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-20.1	-158.2
EV/GP/RG	4.63	4.29
Ticker research	View MRVI research	View PSNL research